Published in Br J Cancer on July 29, 2002
Human transcriptome subtraction by using short sequence tags to search for tumor viruses in conjunctival carcinoma. J Virol (2007) 2.68
The role of infectious agents in the etiology of ocular adnexal neoplasia. Surv Ophthalmol (2008) 1.57
Epidemiology of ocular surface squamous neoplasia in Africa. Trop Med Int Health (2013) 1.50
The challenge of AIDS-related malignancies in sub-Saharan Africa. PLoS One (2010) 1.34
HIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data. Infect Agent Cancer (2011) 1.16
Epidermodysplasia verruciformis human papillomavirus types and carcinoma of the conjunctiva: a pilot study. Br J Cancer (2004) 1.14
Association of human papilloma virus with pterygia and ocular-surface squamous neoplasia. Eye (Lond) (2011) 1.13
Ocular surface squamous neoplasia in patients with HIV infection in sub-Saharan Africa. Curr Opin Oncol (2010) 1.06
Evaluating the role of human papillomaviruses in conjunctival neoplasia. Br J Cancer (2006) 1.04
Evolving spectrum and incidence of non-AIDS-defining malignancies. Curr Opin HIV AIDS (2009) 0.99
Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda. Br J Cancer (2003) 0.94
Genital and cutaneous human papillomavirus (HPV) types in relation to conjunctival squamous cell neoplasia: a case-control study in Uganda. Infect Agent Cancer (2008) 0.94
The viral etiology of AIDS-associated malignancies. Adv Pharmacol (2008) 0.89
Helicobacter pylori and cancer among adults in Uganda. Infect Agent Cancer (2006) 0.89
Antibodies against human papillomavirus type 16 (HPV-16) and conjunctival squamous cell neoplasia in Uganda. Br J Cancer (2003) 0.88
HPV infection and EGFR activation/alteration in HIV-infected East African patients with conjunctival carcinoma. PLoS One (2010) 0.87
[Association of malignant tumors of the conjunctiva and HIV infection in Kinshasa (D. R. Congo). First results]. Ophthalmologe (2004) 0.85
Squamous cell papilloma of the conjunctiva due to human papillomavirus (HPV): presentation of two cases and review of literature. Clin Ophthalmol (2012) 0.84
Low frequency of human papillomavirus infection in conjunctival squamous cell carcinoma of Mexican patients. Infect Agent Cancer (2011) 0.84
HIV and HPV infections and ocular surface squamous neoplasia: systematic review and meta-analysis. Br J Cancer (2013) 0.82
Incidence of squamous-cell carcinoma of the conjunctiva and other eye cancers in the NIH-AARP Diet and Health Study. Ecancermedicalscience (2012) 0.81
[The influence of the HIV pandemic on the incidence of malignant ocular tumours in Southern Malawi (Blantyre)]. Ophthalmologe (2009) 0.79
Trends in cancer incidence in Maputo, Mozambique, 1991-2008. PLoS One (2015) 0.78
Epidemiology of Ocular Surface Squamous Neoplasia in a Veterans Affairs Population. Cornea (2013) 0.77
The aetiology and associations of conjunctival intraepithelial neoplasia: further evidence. Br J Ophthalmol (2007) 0.76
HIV and cancer registry linkage identifies a substantial burden of cancers in persons with HIV in India. Medicine (Baltimore) (2016) 0.75
Ocular surface squamous neoplasia as the initial presenting sign of human immunodeficiency virus infection in 60 Asian Indian patients. Int Ophthalmol (2016) 0.75
Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst (1995) 18.86
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med (1996) 5.96
A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16. J Natl Cancer Inst (1994) 3.95
Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997. Br J Cancer (2000) 3.79
Conjunctival squamous-cell carcinoma associated with HIV infection in Kampala, Uganda. Lancet (1995) 3.05
Evaluation of seroreactivity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia. J Infect Dis (1995) 2.21
Carcinoma of the conjunctiva and HIV infection in Uganda and Malawi. Br J Ophthalmol (1996) 2.01
Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood (1998) 1.95
Effect of ambient solar ultraviolet radiation on incidence of squamous-cell carcinoma of the eye. Lancet (1996) 1.81
A case-control study of human immunodeficiency virus infection and cancer in adults and children residing in Kampala, Uganda. Int J Cancer (2001) 1.75
HIV and conjunctival malignancies. Lancet (1990) 1.48
Epidemiology of squamous cell conjunctival cancer. Cancer Epidemiol Biomarkers Prev (1997) 1.47
Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum (1995) 1.38
IARC monographs on the evaluation of carcinogenic risks to humans. Solar and ultraviolet radiation. IARC Monogr Eval Carcinog Risks Hum (1992) 1.36
Seropositivities to human papillomavirus types 16, 18, or 33 capsids and to Chlamydia trachomatis are markers of sexual behavior. J Infect Dis (1996) 1.36
Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses. J Virol (2002) 1.35
Cancer and HIV infection in Rwanda. Lancet (1995) 1.31
Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer. J Natl Cancer Inst (1997) 1.29
Overview of the epidemiology of immunodeficiency-associated cancers. J Natl Cancer Inst Monogr (1998) 1.28
Risk factors in the development of ocular surface epithelial dysplasia. Ophthalmology (1994) 1.28
Solar keratosis, pterygium, and squamous cell carcinoma of the conjunctiva in Malawi. Br J Ophthalmol (1979) 1.27
The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system. J Clin Microbiol (1998) 1.25
Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda. AIDS (1997) 1.21
A review of the aetiology of squamous cell carcinoma of the conjunctiva. Br J Cancer (1996) 1.21
Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer. Int J Cancer (2002) 1.21
Cancer in Rwanda. Int J Cancer (1996) 1.18
Conjunctival malignant disease with AIDS in USA. Lancet (1995) 1.11
Antibodies to human papillomavirus 16 and subsequent in situ or invasive cancer of the cervix. Cancer Epidemiol Biomarkers Prev (1997) 1.10
Cancer in the African population of Harare, Zimbabwe, 1990-1992. Int J Cancer (1995) 1.08
Detection of antibodies against human papillomavirus (HPV) type 16 virions by enzyme-linked immunosorbent assay using recombinant HPV 16 L1 capsids produced by recombinant baculovirus. J Clin Microbiol (1995) 1.01
Necrotizing scleritis secondary to conjunctival squamous cell carcinoma in acquired immunodeficiency syndrome. Am J Ophthalmol (1990) 0.99
Prospective study of antibody to human papilloma virus type 16 and risk of cervical, endometrial, and ovarian cancers (United States). Cancer Causes Control (2001) 0.93
Conjunctival squamous cell carcinoma combined with malignant lymphoma. Am J Ophthalmol (1975) 0.91
Conjunctival squamous cell carcinoma in a patient with human immunodeficiency virus infection. Am J Ophthalmol (1989) 0.91
Squamous cell carcinoma of the cornea and conjunctiva following a thermal burn of the eye. Cornea (1986) 0.89
[Conjunctival epidermoid carcinoma and human immunodeficiency virus]. J Fr Ophtalmol (1994) 0.87
Prospective study on cervical neoplasia IV. Presence of HPV antibodies. Int J Cancer (1999) 0.87
Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet (1995) 10.63
Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer (2010) 10.61
Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst (2002) 9.65
Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol (2002) 8.88
DRC: a dual route cascaded model of visual word recognition and reading aloud. Psychol Rev (2001) 7.63
Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. Lancet (2015) 7.29
UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet (2000) 7.19
Cancer of the cervix: a sexually transmitted infection? Lancet (1974) 6.93
Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet (2008) 6.67
Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science (1996) 6.57
Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer (1999) 6.11
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med (1996) 5.96
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Mortality of employees of the United Kingdom Atomic Energy Authority, 1946-1979. Br Med J (Clin Res Ed) (1985) 5.48
Cancer registration: principles and methods. Statistical methods for registries. IARC Sci Publ (1991) 5.44
Risk of Kaposi's sarcoma and sexual practices associated with faecal contact in homosexual or bisexual men with AIDS. Lancet (1992) 5.10
Home births in England and Wales, 1979: perinatal mortality according to intended place of delivery. Br Med J (Clin Res Ed) (1984) 4.91
Effects of low doses and low dose rates of external ionizing radiation: cancer mortality among nuclear industry workers in three countries. Radiat Res (1995) 4.85
Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci U S A (1999) 4.52
SAK/PLK4 is required for centriole duplication and flagella development. Curr Biol (2005) 4.52
Sudden fall in breast cancer death rates in England and Wales. Lancet (1995) 4.50
Risk of lung cancer associated with residential radon exposure in south-west England: a case-control study. Br J Cancer (1998) 4.24
HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood (2000) 4.22
The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med (2000) 4.20
Childhood leukaemia in the West Berkshire and Basingstoke and North Hampshire District Health Authorities in relation to nuclear establishments in the vicinity. Br Med J (Clin Res Ed) (1987) 4.17
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet (1996) 4.05
Mortality of employees of the Atomic Weapons Establishment, 1951-82. BMJ (1988) 3.82
Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997. Br J Cancer (2000) 3.79
Cell Surfaces in Plant-Microorganism Interactions: II. Evidence for the Accumulation of Hydroxyproline-rich Glycoproteins in the Cell Wall of Diseased Plants as a Defense Mechanism. Plant Physiol (1979) 3.75
Deviation from prescribed drug treatment after discharge from hospital. Br Med J (1976) 3.35
Estimates of the worldwide frequency of twelve major cancers. Bull World Health Organ (1984) 3.32
Cancer incidence in the United Kingdom: projections to the year 2030. Br J Cancer (2011) 3.23
Acquired immunodeficiency syndrome (AIDS) associated with transfusions. N Engl J Med (1984) 3.22
AIDS-associated non-Hodgkin lymphoma. Lancet (1991) 3.20
Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer (2002) 3.17
Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer (1993) 3.13
Fetal loss, gravidity, and pregnancy order. Early Hum Dev (1978) 3.06
Cancer Incidence in Five Continents. Comparability and quality of data. IARC Sci Publ (1992) 2.99
A case-control study of cervical cancer screening in north east Scotland. Br Med J (Clin Res Ed) (1985) 2.98
Efficacy of postexposure prophylaxis after intravaginal exposure of pig-tailed macaques to a human-derived retrovirus (human immunodeficiency virus type 2). J Virol (2000) 2.97
Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays. J Virol (2001) 2.87
Case-control study of prostatic cancer in employees of the United Kingdom Atomic Energy Authority. BMJ (1993) 2.85
The impact of screening on the incidence of cervical cancer in England and Wales. Br J Obstet Gynaecol (1985) 2.83
Mortality in vegetarians and nonvegetarians: detailed findings from a collaborative analysis of 5 prospective studies. Am J Clin Nutr (1999) 2.78
Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T. Lancet (1994) 2.78
Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet (1995) 2.74
An epidemiological study of recent trends in ectopic pregnancy. Br J Obstet Gynaecol (1975) 2.72
Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas. J Pathol (2006) 2.65
Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. Eur J Cancer (1997) 2.65
Antibodies against human herpesvirus 8 in black South African patients with cancer. N Engl J Med (1999) 2.63
B-cell immunodeficiency in acquired immune deficiency syndrome. JAMA (1984) 2.63
Cancer in Kampala, Uganda, in 1989-91: changes in incidence in the era of AIDS. Int J Cancer (1993) 2.58
Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk. Lancet (1993) 2.58
KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. Oncogene (1997) 2.57
Strategies for global control of cervical cancer. Int J Cancer (1995) 2.52
Predictions of cervical cancer incidence and mortality in England and Wales. Lancet (1986) 2.36
Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev (1997) 2.36
On the estimation of relative risk from vital statistical data. J Epidemiol Community Health (1979) 2.34
Ovarian cancer and smoking: individual participant meta-analysis including 28,114 women with ovarian cancer from 51 epidemiological studies. Lancet Oncol (2012) 2.33
Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group. Arch Intern Med (1996) 2.33
Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children. Controlled trial in an endemic area (Senegal). Lancet (1981) 2.31
Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br J Cancer (2004) 2.30
Cardiovascular-disease mortality trends and oral-contraceptive use in young women. Lancet (1976) 2.29
Does pregnancy protect against ovarian cancer? Lancet (1978) 2.28
Malignant melanoma and exposure to fluorescent lighting at work. Lancet (1982) 2.28
Familial granulomatous arthritis (Blau syndrome) with granulomatous renal lesions. J Pediatr (1998) 2.27
Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer (2006) 2.27
A comparison of standardized and proportional mortality ratios. Stat Med (1984) 2.27
The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1. J Virol (1997) 2.24
Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line. Virology (1999) 2.23
Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Cancer Inst (1998) 2.23
Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J Natl Cancer Inst (1990) 2.23
Mortality among oral-contraceptive users. Royal College of General Practitioners' Oral Contraception Study. Lancet (1977) 2.21
Detection of human herpesvirus 8 DNA in semen from HIV-infected individuals but not healthy semen donors. AIDS (1997) 2.20
Coxsackie B virus serology and Type 1 diabetes mellitus: a systematic review of published case-control studies. Diabet Med (2004) 2.18
Lifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohort. Br J Cancer (2008) 2.15
Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer (2003) 2.14
Pooled analysis of 3 European case-control studies of ovarian cancer: II. Age at menarche and at menopause. Int J Cancer (1991) 2.14
Seven-year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal). Lancet (1986) 2.14
Collection and validation of data in the United Kingdom Atomic Energy Authority mortality study. Br Med J (Clin Res Ed) (1985) 2.13
Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome. J Hum Virol (1999) 2.09
Screening for liver cancer: results of a randomised controlled trial in Qidong, China. J Med Screen (2003) 2.07
Mortality in women in relation to their childbearing history. BMJ (1988) 2.06